IMARC Group: Market Research Reports

The International Market Analysis Research and Consulting Group (IMARC Group) has been keeping the top position in terms of provision consultancy services on management strategy and market for above 5 years.

IMARC Group serves customers from diverse industry areas in various regions of the globe by identifying their premium-value biz opps, dealing with their most burning issues, and converting their businesses. The company bears its clients a hand in improving decision-making and strategy-planning processes as well as in moving their business to a higher level.

The reports published by IMARC offer precise information on a slew of industries such as pharmaceutical, high-technology, advanced materials, food and beverage, biotechnology, nanotechnology, tourism and travel and a far more. The reports include detailed market analyses, overviews and forecasts, reviews of the economic and technological developments, profiles of the dominant companies, market/product assessments, etc. IMARC’s research approach unites deep insight into the market dynamics together with strong cooperation with each level of the client organization.

Publications found: 13,315

Sort by:

Medulloblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major medulloblastoma markets are expected to exhibit a CAGR of 6.05% during 2024-2034. The medulloblastoma market has been comprehensively analyzed in IMARC's new report titled 'Medulloblastoma...

May 2024 136 pages

Meibomian Gland Dysfunction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meibomian gland dysfunction markets reached a value of US$ 2.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAG...

May 2024 135 pages

Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major melanoma markets reached a value of US$ 3.9 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 8.9 Billion by 2034, exhibiting a growth rate (CAGR) of 7.93% during...

May 2024 135 pages

MELAS Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The MELAS Syndrome market reached a value of US$ 154.8 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 447.7 Million by 203...

May 2024 138 pages

Membranous Nephropathy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major membranous nephropathy markets reached a value of US$ 125.8 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 190.5 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 131 pages

Memory Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major memory disorders markets are expected to exhibit a CAGR of 5.42% during 2024-2034. The memory disorders market has been comprehensively analyzed in IMARC's new report titled 'Memory Disord...

May 2024 138 pages

Meniere's Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Meniere's disease markets are expected to exhibit a CAGR of 2.38% during 2024-2034. The Meniere's disease market has been comprehensively analyzed in IMARC's new report titled 'Meniere's D...

May 2024 140 pages

Meningioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningioma markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 9.79% durin...

May 2024 129 pages

Meningitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major meningitis markets are expected to exhibit a CAGR of 3.3% during 2024-2034. The meningitis market has been comprehensively analyzed in IMARC's new report titled 'Meningitis Market: Epidemi...

May 2024 131 pages

Menkes Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Menkes disease markets are expected to exhibit a CAGR of 5.88% during 2024-2034. The Menkes disease market has been comprehensively analyzed in IMARC's new report titled 'Menkes Disease Ma...

May 2024 133 pages

Menorrhagia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major menorrhagia markets reached a value of US$ 970 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,380 Million by 2034, exhibiting a growth rate (CAGR) of 3.26% du...

May 2024 137 pages

Merkel Cell Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Merkel cell carcinoma markets reached a value of US$ 2.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 3.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Mesothelioma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mesothelioma markets reached a value of US$ 434.2 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 905.6 Million by 2034, exhibiting a growth rate (CAGR) of 6.91%...

May 2024 133 pages

Metabolic Acidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metabolic acidosis markets are expected to exhibit a CAGR of 5.76% during 2024-2034. The metabolic acidosis market has been comprehensively analyzed in IMARC's new report titled 'Metabolic...

May 2024 140 pages

Metachromatic Leukodystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

US$ 6,499.00

The 7 major metachromatic leukodystrophy markets reached a value of US$ 2.5 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.2 Billion by 2034, exhibiting a growth rate (CA...

May 2024 133 pages

Metastatic Castration-Resistant Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic castration-resistant prostate cancer markets are expected to exhibit a CAGR of 5.44% during 2024-2034. The metastatic castration-resistant prostate cancer market has been compre...

May 2024 138 pages

Metastatic Cutaneous Squamous Cell Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic cutaneous squamous cell cancer markets are expected to exhibit a CAGR of 5.64% during 2024-2034. The metastatic cutaneous squamous cell cancer market has been comprehensively an...

May 2024 140 pages

Metastatic Hepatocellular Carcinoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic hepatocellular carcinoma markets are expected to exhibit a CAGR of 13.63% during 2024-2034. The metastatic hepatocellular carcinoma market has been comprehensively analyzed in I...

May 2024 135 pages

Metastatic HER2-Positive Breast Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic HER2-positive breast cancer markets are expected to exhibit a CAGR of 1.18% during 2024-2034. The metastatic HER2-positive breast cancer market has been comprehensively analyzed...

May 2024 138 pages

Metastatic Melanoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic melanoma markets are expected to exhibit a CAGR of 8.23% during 2024-2034. The metastatic melanoma market has been comprehensively analyzed in IMARC's new report titled 'Metasta...

May 2024 132 pages

Metastatic Prostate Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major metastatic prostate cancer markets are expected to exhibit a CAGR of 6.22% during 2024-2034. The metastatic prostate cancer market has been comprehensively analyzed in IMARC's new report t...

May 2024 138 pages

Mild Cognitive Impairment Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mild cognitive impairment markets are expected to exhibit a CAGR of 4.02% during 2024-2034. The mild cognitive impairment market has been comprehensively analyzed in IMARC's new report tit...

May 2024 137 pages

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major minimal residual disease markets reached a value of US$ 855.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,261.0 Million by 2034, exhibiting a growth rate (...

May 2024 138 pages

Mitochondrial Myopathies Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mitochondrial myopathies markets reached a value of US$ 22.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 34.8 Million by 2034, exhibiting a growth rate (CAGR...

May 2024 134 pages

Mood Disorders Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mood disorders markets reached a value of US$ 3.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR) of 1.78% d...

May 2024 128 pages

Morquio Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Morquio syndrome markets are expected to exhibit a CAGR of 4.45% during 2024-2034. The Morquio syndrome market has been comprehensively analyzed in IMARC's new report titled 'Morquio Syndr...

May 2024 134 pages

Motor Neuron Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major motor neuron disease markets reached a value of US$ 6.7 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.8 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 130 pages

Mouth Neoplasms Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mouth neoplasms markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.0 Billion by 2034, exhibiting a growth rate (CAGR) of 3.69%...

May 2024 137 pages

Mucopolysaccharidoses Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mucopolysaccharidoses markets are expected to exhibit a CAGR of 5.9% during 2024-2034. The mucopolysaccharidoses market has been comprehensively analyzed in IMARC's new report titled 'Muco...

May 2024 128 pages

Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The mucopolysaccharidosis market has been comprehensively analyzed in IMARC's new report titled 'Mucopolysaccharidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Fore...

May 2024 138 pages

Multiple Endocrine Neoplasia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple endocrine neoplasia markets are expected to exhibit a CAGR of 10.2% during 2024-2034. The multiple endocrine neoplasia market has been comprehensively analyzed in IMARC's new repo...

May 2024 132 pages

Multiple System Atrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major multiple system atrophy markets reached a value of US$ 129.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 187.2 Million by 2034, exhibiting a growth rate (CAG...

May 2024 134 pages

Muscle Spasticity Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major muscle spasticity markets reached a value of US$ 3.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 6.9 Billion by 2034, exhibiting a growth rate (CAGR) of 6.84...

May 2024 128 pages

Musculoskeletal Pain Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major musculoskeletal pain markets reached a value of US$ 3,975.7 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5,399.8 Million by 2034, exhibiting a growth rate (CA...

May 2024 134 pages

Myasthenia Gravis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myasthenia gravis markets reached a value of US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.1 Billion by 2034, exhibiting a growth rate (CAGR) of 4.99...

May 2024 134 pages

Mycosis Fungoides Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mycosis fungoides markets are expected to exhibit a CAGR of 4.9% during 2024-2034. The mycosis fungoides market has been comprehensively analyzed in IMARC's new report titled 'Mycosis Fung...

May 2024 129 pages

Mydriasis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major mydriasis markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The mydriasis market has been comprehensively analyzed in IMARC's new report titled 'Mydriasis Market: Epidemiol...

May 2024 137 pages

Myelodysplastic Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myelodysplastic syndrome markets reached a value of US$ 2.3 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 136 pages

Myocardial Infarction Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocardial infarction markets reached a value of US$ 1.4 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2.4 Billion by 2034, exhibiting a growth rate (CAGR) of...

May 2024 137 pages

Myocarditis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myocarditis markets reached a value of US$ 1,373.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 2,281.7 Million by 2034, exhibiting a growth rate (CAGR) of 4....

May 2024 131 pages

Myofascial Pain Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myofascial pain syndromes markets are expected to exhibit a CAGR of 2.69% during 2024-2034. The myofascial pain syndromes market has been comprehensively analyzed in IMARC's new report tit...

May 2024 135 pages

Myopia Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myopia markets are expected to exhibit a CAGR of 6.14% during 2024-2034. The myopia market has been comprehensively analyzed in IMARC's new report titled 'Myopia Market: Epidemiology, Indu...

May 2024 138 pages

Myotonic Dystrophy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major myotonic dystrophy markets reached a value of US$ 96.5 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 260.4 Million by 2034, exhibiting a growth rate (CAGR) of...

May 2024 139 pages

Nasal Polyps Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nasal polyps markets reached a value of US$ 68.6 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 109.0 Million by 2034, exhibiting a growth rate (CAGR) of 4.3% d...

May 2024 137 pages

Nasopharyngeal Cancer Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major nasopharyngeal cancer markets reached a value of US$ 858.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,075.5 Million by 2034, exhibiting a growth rate (CAG...

May 2024 128 pages

Necrotizing Enterocolitis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major necrotizing enterocolitis markets reached a value of US$ 3.6 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 5.5 Billion by 2034, exhibiting a growth rate (CAGR)...

May 2024 128 pages

Neonatal Sepsis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neonatal sepsis markets are expected to exhibit a CAGR of 7.12% during 2024-2034. The neonatal sepsis market has been comprehensively analyzed in IMARC's new report titled 'Neonatal Sepsis...

May 2024 133 pages

Netherton Syndrome Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major Netherton syndrome markets reached a value of US$ 21.4 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 69.7 Million by 2034, exhibiting a growth rate (CAGR) of 1...

May 2024 132 pages

Neuroblastoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neuroblastoma markets reached a value of US$ 256.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 328.2 Million by 2034, exhibiting a growth rate (CAGR) of 2.28...

May 2024 130 pages

Neurocutaneous Syndromes Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

US$ 6,499.00

The 7 major neurocutaneous syndromes markets are expected to exhibit a CAGR of 6.63% during 2024-2034 The neurocutaneous syndromes market has been comprehensively analyzed in IMARC's new report titled...

May 2024 138 pages

Filters

Clear all